​

ANI Pharmaceuticals Ownership | Who Owns ANI Pharmaceuticals?

OverviewForecastRevenueFinancialsChartTranscripts

ANI Pharmaceuticals Ownership Summary

ANI Pharmaceuticals is owned by 31.62% institutional investors, 6.89% insiders, and 61.49% retail investors. Blackrock is the largest institutional shareholder, holding 13.91% of ANIP shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 4.82% of its assets in ANI Pharmaceuticals shares.

ANIP Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockANI Pharmaceuticals31.62%6.89%61.49%
SectorHealthcare Stocks 35.49%11.78%52.72%
IndustrySpecialty & Generic Drug Manufacturers Stocks20.39%13.84%65.77%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock2.66M13.91%$169.17M
Blackrock funding, inc. /de2.75M13.70%$211.28M
Vanguard group1.31M6.50%$103.02M
Soleus capital management820.24K4.09%$63.08M
State street771.59K3.85%$59.34M
Tang capital management707.50K3.53%$54.41M
Goldentree asset management lp667.98K3.33%$51.30M
Deep track capital, lp600.00K2.99%$46.14M
Millennium management592.01K2.95%$45.53M
Arrowstreet capital, limited partnership564.36K2.81%$43.40M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Goldentree asset management lp667.98K3.04%$51.30M
Sio capital management265.54K2.93%$20.42M
Tang capital management707.50K2.76%$54.41M
Soleus capital management820.24K2.55%$63.08M
Parkman healthcare partners280.57K2.23%$21.58M
Ranger investment management360.08K2.00%$27.69M
Global alpha capital management361.24K1.67%$27.78M
Marathon capital management72.59K1.26%$5.58M
Penn capital management company179.72K1.07%$13.83M
Globeflex capital l p84.14K0.98%$6.47M

Top Buyers

HolderShares% AssetsChange
Goldentree asset management lp667.98K3.04%667.98K
Ubs group497.70K0.01%346.92K
Soleus capital management820.24K2.55%334.00K
Divisadero street capital management, lp234.22K0.94%234.22K
Tang capital management707.50K2.76%226.06K

Top Sellers

HolderShares% AssetsChange
Rubric capital management lp---343.41K
Macquarie group---291.13K
Global alpha capital management361.24K1.67%-228.90K
Balyasny asset management---205.09K
Apis capital advisors---196.00K

New Positions

HolderShares% AssetsChangeValue
Goldentree asset management lp667.98K3.04%667.98K$51.30M
Divisadero street capital management, lp234.22K0.94%234.22K$21.45M
Ikarian capital147.09K0.92%147.09K$11.31M
Vanguard fiduciary trust127.19K0.00%127.19K$9.78M
Ruffer llp60.19K0.19%60.19K$4.64M

Sold Out

HolderChange
Mendota financial group-1.00
Tortoise investment management-1.00
Financial gravity asset management-1.00
Nelson, van denburg & campbell wealth management group-1.00
Cbiz investment advisory services-2.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2026132-54.79%6,340,720-70.04%310.28%71-56.97%36-52.63%
Dec 31, 202583-69.71%3,388,014-83.40%160.16%37-74.66%27-67.86%
Sep 30, 202599-55.61%3,677,102-80.25%180.21%49-57.76%29-57.97%
Jun 30, 2025224-2.18%19,142,922-4.15%960.93%1145.56%70-4.11%
Mar 31, 202522911.16%19,974,4243.61%1011.03%11011.11%7220.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF1.10M4.82%267.00
Vanguard US Total Market Shares ETF588.25K2.73%-
Vanguard Total Stock Mkt Idx Inv600.93K2.64%-
Pacer US Small Cap Cash Cows 100 ETF549.63K2.62%-1.87K
iShares Russell 2000 ETF442.18K1.94%3.71K
Delaware Ivy Small Cap Growth C336.40K1.60%-
Macquarie Small Cap Growth C264.83K1.22%-
Ranger Small Cap259.45K1.14%-1.94K
Avantis US Small Cap Value ETF242.38K1.07%-
CREF Stock R3211.19K0.97%-534.00

Recent Insider Transactions

DateNameRoleActivityValue
May 11, 2026Walsh Patrick D-Sell$320.82K
May 13, 2026Walsh Patrick D-Sell$806.30K
May 12, 2026Rowland Thomas Andrew SVP, HEAD - ESTABLISHED BRANDSSell$36.36K
May 11, 2026Lalwani Nikhil PRESIDENT & CEOSell$4.27M
May 12, 2026Gutwerg Ori SVP, GENERICSSell$220.37K

Insider Transactions Trends

DateBuySell
2026 Q2-7
2026 Q1-18
2025 Q4-8
2025 Q3-22
2025 Q2-6

ANIP Ownership FAQ

Who Owns ANI Pharmaceuticals?

ANI Pharmaceuticals shareholders are primarily institutional investors at 31.62%, followed by 6.89% insiders and 61.49% retail investors. The average institutional ownership in ANI Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 20.39%, which ANI Pharmaceuticals exceeds.

Who owns the most shares of ANI Pharmaceuticals?

ANI Pharmaceuticals’s largest shareholders are Blackrock (2.66M shares, 13.91%), Blackrock funding, inc. /de (2.75M shares, 13.70%), and Vanguard group (1.31M shares, 6.50%). Together, they hold 34.11% of ANI Pharmaceuticals’s total shares outstanding.

Does Blackrock own ANI Pharmaceuticals?

Yes, BlackRock owns 13.91% of ANI Pharmaceuticals, totaling 2.66M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 169.17M$. In the last quarter, BlackRock increased its holdings by 125.17K shares, a 4.94% change.

Who is ANI Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Goldentree asset management lp is ANI Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 3.04% of its assets in 667.98K ANI Pharmaceuticals shares, valued at 51.3M$.

Who is the top mutual fund holder of ANI Pharmaceuticals shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of ANI Pharmaceuticals shares, with 4.82% of its total shares outstanding invested in 1.1M ANI Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools